Find a Physician

The Find your Physician resource ("Resource") provided here is intended for use by the general public as a quick reference for patients wanting to locate physicians who perform procedures with the iTind(tm) device. Olympus America Inc. and its parents, subsidiaries, affiliates, directors, officers, employees, agents, and representatives (collectively "Olympus") does not, in anyway, endorse the individuals, institutions or group practices included in the Resource. Similarly, any omission from the Resource does not suggest disapproval or any other position or assessment by Olympus.

*Disclaimer* Any content or information ("Content") presented in this Resource is illustrative in nature and does not guarantee or represent specific information, outcomes, or results. Olympus does not represent or warrant the accuracy or applicability of the Content. Under no circumstances shall Olympus be liable for any costs, expenses, loses, claims, liabilities, or other damages (whether direct, indirect, special, incidental, consequential, or otherwise) that may arise from, or be incurred in connection with, the Content or any use thereof.

Content shall not be downloaded, republished, resold, or duplicated in whole or in part, for commercial or any other purposes, including without limitation compiling mailing lists or any other physician list. The use of Content to establish independent data files or compendiums of statistical information is strictly prohibited.

The iTind Center of Excellence Program is designed to enhance patient outcomes and experiences. Urologists included in the iTind Center of Excellence Program have advanced training and experience with the iTind™ procedure and have demonstrated a commitment to care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH). Urologists must meet all program requirements in a calendar year to qualify for the iTind Center of Excellence designation.

Program Requirements

Completion of iTind™ Training Program
– Continuum™ Online Training + Sign Off by iTind™ Certified Trainer (~5 cases)
Completion of a minimum of 25 iTind procedures between January and December 2025
Submission of de-identified data (baseline and post-treatment IPSS score) on a minimum of 10 iTind™ patients demonstrating mean improvement in IPSS of 30%* or greater compared to baseline average**
Primary practice website must maintain current and accurate education information on BPH disease state
Participation in two 30-minute meetings with an Olympus® representative to review de-identified patient outcomes and share best practices
Participation in one Olympus® iTind™ educational event per calendar year to maintain iTind Center of Excellence status
*The required improvement of 30% or more is in accordance with the FDA guideline for BPH treatments, published in 2021.
**Data collected will be for internal-use only and never published; only used to confirm physician’s competence and experience treating patients with the iTind procedure.